ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could tame prostate cancer by blocking testosterone
Disease control OngoingThis study tests a new long-acting injection called Debio 4228 for men with advanced prostate cancer. The goal is to lower testosterone levels to control the cancer. About 55 men will receive different doses to find the best one. This is not a cure, but a way to manage the diseas…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Prostate cancer study aims to restore testosterone after Long-Term therapy
Disease control OngoingThis study looks at whether testosterone levels can return to normal after two years of treatment with relugolix and darolutamide in men with hormone-sensitive prostate cancer. About 33 participants will receive the drug combination and be monitored for testosterone recovery and …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Atish Choudhury, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Shorter radiation may be as safe for High-Risk prostate cancer
Disease control OngoingThis phase 2 trial tests whether a shorter, more intense radiation course (SBRT) causes fewer side effects than standard daily radiation (IMRT) in men with high-risk prostate cancer. Both groups also receive hormone therapy. The study will compare side effects, quality of life, a…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New adaptive therapy aims to outsmart prostate cancer
Disease control OngoingThis early-phase trial tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. Instead of a fixed schedule, the treatment is adjusted based on PSA levels. The study includes 17 participants and combines standar…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC